339 related articles for article (PubMed ID: 30666257)
1. Pneumococcal Immunization Reduces Neurological and Hepatic Symptoms in a Mouse Model for Niemann-Pick Type C1 Disease.
Houben T; Magro Dos Reis I; Oligschlaeger Y; Steinbusch H; Gijbels MJJ; Hendrikx T; Binder CJ; Cassiman D; Westerterp M; Prickaerts J; Shiri-Sverdlov R
Front Immunol; 2018; 9():3089. PubMed ID: 30666257
[TBL] [Abstract][Full Text] [Related]
2. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
[TBL] [Abstract][Full Text] [Related]
3. Dietary plant stanol ester supplementation reduces peripheral symptoms in a mouse model of Niemann-Pick type C1 disease.
Magro Dos Reis I; Houben T; Oligschläger Y; Bücken L; Steinbusch H; Cassiman D; Lütjohann D; Westerterp M; Prickaerts J; Plat J; Shiri-Sverdlov R
J Lipid Res; 2020 Jun; 61(6):830-839. PubMed ID: 32291331
[TBL] [Abstract][Full Text] [Related]
4. Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1.
Chandler RJ; Williams IM; Gibson AL; Davidson CD; Incao AA; Hubbard BT; Porter FD; Pavan WJ; Venditti CP
Hum Mol Genet; 2017 Jan; 26(1):52-64. PubMed ID: 27798114
[TBL] [Abstract][Full Text] [Related]
5. Normalization of Hepatic Homeostasis in the
Munkacsi AB; Hammond N; Schneider RT; Senanayake DS; Higaki K; Lagutin K; Bloor SJ; Ory DS; Maue RA; Chen FW; Hernandez-Ono A; Dahlson N; Repa JJ; Ginsberg HN; Ioannou YA; Sturley SL
J Biol Chem; 2017 Mar; 292(11):4395-4410. PubMed ID: 28031458
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Potential Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Niemann-Pick Disease, Type C1.
Cawley NX; Lyons AT; Abebe D; Wassif CA; Porter FD
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244519
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease.
Torres S; Matías N; Baulies A; Nuñez S; Alarcon-Vila C; Martinez L; Nuño N; Fernandez A; Caballeria J; Levade T; Gonzalez-Franquesa A; Garcia-Rovés P; Balboa E; Zanlungo S; Fabrías G; Casas J; Enrich C; Garcia-Ruiz C; Fernández-Checa JC
Redox Biol; 2017 Apr; 11():60-72. PubMed ID: 27888692
[TBL] [Abstract][Full Text] [Related]
8. A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations.
Maue RA; Burgess RW; Wang B; Wooley CM; Seburn KL; Vanier MT; Rogers MA; Chang CC; Chang TY; Harris BT; Graber DJ; Penatti CA; Porter DM; Szwergold BS; Henderson LP; Totenhagen JW; Trouard TP; Borbon IA; Erickson RP
Hum Mol Genet; 2012 Feb; 21(4):730-50. PubMed ID: 22048958
[TBL] [Abstract][Full Text] [Related]
9. Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1.
Rodriguez-Gil JL; Watkins-Chow DE; Baxter LL; Elliot G; Harper UL; Wincovitch SM; Wedel JC; Incao AA; Huebecker M; Boehm FJ; Garver WS; Porter FD; Broman KW; Platt FM; Pavan WJ
Dis Model Mech; 2020 Mar; 13(3):. PubMed ID: 31996359
[TBL] [Abstract][Full Text] [Related]
10. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.
Ramirez CM; Liu B; Taylor AM; Repa JJ; Burns DK; Weinberg AG; Turley SD; Dietschy JM
Pediatr Res; 2010 Oct; 68(4):309-15. PubMed ID: 20581737
[TBL] [Abstract][Full Text] [Related]
11. The adenosine A
Ferrante A; Pezzola A; Matteucci A; Di Biase A; Attorri L; Armida M; Martire A; Chern Y; Popoli P
Neurobiol Dis; 2018 Feb; 110():1-11. PubMed ID: 29079454
[TBL] [Abstract][Full Text] [Related]
12. Reduction of glutamate neurotoxicity: A novel therapeutic approach for Niemann-Pick disease, type C1.
Cougnoux A; Yerger JC; Fellmeth M; Serra-Vinardell J; Navid F; Wassif CA; Cawley NX; Porter FD
Mol Genet Metab; 2021 Dec; 134(4):330-336. PubMed ID: 34802899
[TBL] [Abstract][Full Text] [Related]
13. Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
Caporali P; Bruno F; Palladino G; Dragotto J; Petrosini L; Mangia F; Erickson RP; Canterini S; Fiorenza MT
Acta Neuropathol Commun; 2016 Sep; 4(1):94. PubMed ID: 27586038
[TBL] [Abstract][Full Text] [Related]
14. Necroptosis in Niemann-Pick disease, type C1: a potential therapeutic target.
Cougnoux A; Cluzeau C; Mitra S; Li R; Williams I; Burkert K; Xu X; Wassif CA; Zheng W; Porter FD
Cell Death Dis; 2016 Mar; 7(3):e2147. PubMed ID: 26986514
[TBL] [Abstract][Full Text] [Related]
15. Niemann-Pick C1-deficient mice lacking sterol O-acyltransferase 2 have less hepatic cholesterol entrapment and improved liver function.
Lopez AM; Jones RD; Repa JJ; Turley SD
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G454-G463. PubMed ID: 29878847
[TBL] [Abstract][Full Text] [Related]
16. A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele.
Praggastis M; Tortelli B; Zhang J; Fujiwara H; Sidhu R; Chacko A; Chen Z; Chung C; Lieberman AP; Sikora J; Davidson C; Walkley SU; Pipalia NH; Maxfield FR; Schaffer JE; Ory DS
J Neurosci; 2015 May; 35(21):8091-106. PubMed ID: 26019327
[TBL] [Abstract][Full Text] [Related]
17. Gene Therapy in a Mouse Model of Niemann-Pick Disease Type C1.
Kurokawa Y; Osaka H; Kouga T; Jimbo E; Muramatsu K; Nakamura S; Takayanagi Y; Onaka T; Muramatsu SI; Yamagata T
Hum Gene Ther; 2021 Jun; 32(11-12):589-598. PubMed ID: 33256498
[TBL] [Abstract][Full Text] [Related]
18. Quantitative, Label-Free Proteomics in the Symptomatic Niemann-Pick, Type C1 Mouse Model Using Standard Flow Liquid Chromatography and Thermal Focusing Electrospray Ionization.
Pergande MR; Nguyen TTA; Haney-Ball C; Davidson CD; Cologna SM
Proteomics; 2019 May; 19(9):e1800432. PubMed ID: 30888112
[TBL] [Abstract][Full Text] [Related]
19. Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage.
Ilnytska O; Lai K; Gorshkov K; Schultz ML; Tran BN; Jeziorek M; Kunkel TJ; Azaria RD; McLoughlin HS; Waghalter M; Xu Y; Schlame M; Altan-Bonnet N; Zheng W; Lieberman AP; Dobrowolski R; Storch J
J Biol Chem; 2021 Jul; 297(1):100813. PubMed ID: 34023384
[TBL] [Abstract][Full Text] [Related]
20. The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity.
Zhou Y; Takahashi S; Homma K; Duan C; Zheng J; Cheatham MA; Zheng J
Acta Neuropathol Commun; 2018 Sep; 6(1):98. PubMed ID: 30249300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
